113 related articles for article (PubMed ID: 18590129)
1. [Production of hepatitis B virus core particles protein in plants, by using cowpea mosaic virus-based vector].
Meshcheriakova IuA; El'darov MA; Beales L; Skriabin KG; Lomonossoff GP
Vopr Virusol; 2008; 53(3):15-20. PubMed ID: 18590129
[TBL] [Abstract][Full Text] [Related]
2. The use of viral vectors to produce hepatitis B virus core particles in plants.
Mechtcheriakova IA; Eldarov MA; Nicholson L; Shanks M; Skryabin KG; Lomonossoff GP
J Virol Methods; 2006 Jan; 131(1):10-5. PubMed ID: 16112207
[TBL] [Abstract][Full Text] [Related]
3. Development of cowpea mosaic virus-based vectors for the production of vaccines in plants.
Cañizares MC; Lomonossoff GP; Nicholson L
Expert Rev Vaccines; 2005 Oct; 4(5):687-97. PubMed ID: 16221070
[TBL] [Abstract][Full Text] [Related]
4. Plant-produced recombinant influenza vaccine based on virus-like HBc particles carrying an extracellular domain of M2 protein.
Ravin NV; Kotlyarov RY; Mardanova ES; Kuprianov VV; Migunov AI; Stepanova LA; Tsybalova LM; Kiselev OI; Skryabin KG
Biochemistry (Mosc); 2012 Jan; 77(1):33-40. PubMed ID: 22339631
[TBL] [Abstract][Full Text] [Related]
5. Simple method for efficient production of hepatitis B virus core antigen in Escherichia coli.
Naito M; Ishii K; Nakamura Y; Kobayashi M; Takada S; Koike K
Res Virol; 1997; 148(4):299-305. PubMed ID: 9272581
[TBL] [Abstract][Full Text] [Related]
6. Co-expression of the hepatitis B surface and core antigens using baculovirus multiple expression vectors.
Takehara K; Ireland D; Bishop DH
J Gen Virol; 1988 Nov; 69 ( Pt 11)():2763-77. PubMed ID: 3053987
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus.
Nemecková S; Sroller V; Kunke D; Krystofová J; Kutinová L
Acta Virol; 1996; 40(5-6):273-9. PubMed ID: 9171455
[TBL] [Abstract][Full Text] [Related]
8. Exploring different strategies to express Dengue virus envelope protein in a plant system.
Martínez CA; Topal E; Giulietti AM; Talou JR; Mason H
Biotechnol Lett; 2010 Jun; 32(6):867-75. PubMed ID: 20213522
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of the epitope of the foot-and-mouth disease virus fused with a hepatitis B core protein as expressed in transgenic tobacco.
Huang Y; Liang W; Wang Y; Zhou Z; Pan A; Yang X; Huang C; Chen J; Zhang D
Viral Immunol; 2005; 18(4):668-77. PubMed ID: 16359233
[TBL] [Abstract][Full Text] [Related]
10. Cowpea mosaic virus-based systems for the expression of antigens and antibodies in plants.
Sainsbury F; Liu L; Lomonossoff GP
Methods Mol Biol; 2009; 483():25-39. PubMed ID: 19183891
[TBL] [Abstract][Full Text] [Related]
11. Expression of HBcAg mutant with long internal deletion in Saccharomyces cerevisiae and observation of its self-assembly particles by atomic force microscopy (AFM).
Chen H; Liu S; Chen L; Huang J; Xiang S
Int J Biol Macromol; 2005 Dec; 37(5):239-48. PubMed ID: 16414112
[TBL] [Abstract][Full Text] [Related]
12. Meeting report VLPNPV: Session 5: Plant based technology.
Meador LR; Mor TS
Hum Vaccin Immunother; 2014; 10(10):3068-73. PubMed ID: 25581535
[TBL] [Abstract][Full Text] [Related]
13. Physicochemical analysis of the hepatitis B virus core antigen produced by a baculovirus expression vector.
Hilditch CM; Rogers LJ; Bishop DH
J Gen Virol; 1990 Nov; 71 ( Pt 11)():2755-9. PubMed ID: 2254755
[TBL] [Abstract][Full Text] [Related]
14. Expression of multiple proteins using full-length and deleted versions of cowpea mosaic virus RNA-2.
Sainsbury F; Lavoie PO; D'Aoust MA; Vézina LP; Lomonossoff GP
Plant Biotechnol J; 2008 Jan; 6(1):82-92. PubMed ID: 17986176
[TBL] [Abstract][Full Text] [Related]
15. Suitability of yeast- and Escherichia coli-expressed hepatitis B virus core antigen derivatives for detection of anti-HBc antibodies in human sera.
Li ZX; Hong GQ; Hu B; Liang MJ; Xu J; Li L
Protein Expr Purif; 2007 Dec; 56(2):293-300. PubMed ID: 17897838
[TBL] [Abstract][Full Text] [Related]
16. Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice.
Huang Z; Santi L; LePore K; Kilbourne J; Arntzen CJ; Mason HS
Vaccine; 2006 Mar; 24(14):2506-13. PubMed ID: 16417953
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of recombinant Human Papillomavirus 8 L1 production in plants by a variety of expression systems and purification methods.
Matić S; Masenga V; Poli A; Rinaldi R; Milne RG; Vecchiati M; Noris E
Plant Biotechnol J; 2012 May; 10(4):410-21. PubMed ID: 22260326
[TBL] [Abstract][Full Text] [Related]
18. [Hepatitis B virus core antigen as a carrier for virus-like partical vaccine: a review].
Yang XY; Bo H; Shu YL
Bing Du Xue Bao; 2012 May; 28(3):311-6. PubMed ID: 22764537
[TBL] [Abstract][Full Text] [Related]
19. [Cloning and expression of the hepatitis B virus HBcAg gene in eukaryotic cells].
Bulut Y; Doymaz MZ
Mikrobiyol Bul; 2002 Apr; 36(2):183-91. PubMed ID: 12652871
[TBL] [Abstract][Full Text] [Related]
20. Protoplasts transiently expressing the 200K coding sequence of cowpea mosaic virus B-RNA support replication of M-RNA.
van Bokhoven H; Verver J; Wellink J; van Kammen A
J Gen Virol; 1993 Oct; 74 ( Pt 10)():2233-41. PubMed ID: 8409945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
